26.10.2011
- With more and more players in big pharma looking to outsource in order to focus on core competencies, custom manufacturers stand to benefit from this shift. The most exciting trend...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
20.10.2011
- Up To Task - Facing a huge patent cliff and a less-than-robust pipeline, pharma companies must look to customized and personalized medicines. This is where API manufacturers are...
14.09.2010
- The name of the game is focusing on core competencies - and this is something custom manufacturers have been able to benefit from over the last several years. This trend has set...
Bertrand Piccard is considered a pioneer in looking at the environment from an economic point of view and has been promoting renewable energy and clean technologies for...
Chemicals are a critical, but often overlooked, factor of success for a circular economy. 96% of all products on European markets, from food to medical treatments, from...
Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...
The change in many chemical companies’ product portfolio away from commodities to customer-specific specialties is one of the current challenges facing the process...
The chemical industry is on the threshold of a new era – the age of circularity. We asked industry experts to share their opinions on this transformational topic.
25.09.2012
- CHEManager Europe asked experts from the pharmaceutical ingredients and custom synthesis industry to share their opinions on this topic prior to the industry global networking...